Holen Sie sich die Stockscreener-App
1.74
6.45%
-0.12
Vorhandelsmarkt:
1.74
Schlusskurs vom Vortag:
$1.86
Offen:
$1.86
24-Stunden-Volumen:
896.06K
Relative Volume:
1.04
Marktkapitalisierung:
$68.92M
Einnahmen:
$41.21M
Nettoeinkommen (Verlust:
$-15.12M
KGV:
-4.8347
EPS:
-0.3599
Netto-Cashflow:
$-17.19M
1W Leistung:
+19.18%
1M Leistung:
+93.33%
6M Leistung:
+137.74%
1J Leistung:
+55.36%
1-Tages-Spanne:
$1.685
$1.86
1-Wochen-Bereich:
$1.42
$1.885
52-Wochen-Spanne:
$0.605
$1.885
Myomo Inc Stock (MYO) Company Profile
Firmenname
Myomo Inc
Sektor
Branche
Telefon
617-996-9058
Adresse
One Broadway, 14th Floor, Cambridge, MA
Compare MYO vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MYO
Myomo Inc
|
1.74 | 73.67M | 41.21M | -15.12M | -17.19M | -0.3599 |
ABT
Abbott Laboratories
|
114.14 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
327.70 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.30 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.37 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.83 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Myomo Inc Stock (MYO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-31 | Eingeleitet | Craig Hallum | Buy |
| 2024-05-20 | Eingeleitet | Lake Street | Buy |
| 2023-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-11-11 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2020-05-27 | Eingeleitet | Dougherty & Company | Buy |
| 2017-10-02 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Myomo Inc Aktie (MYO) Neueste Nachrichten
Myomo (NYSE: MYO) officer eyes 17,500-share stock sale - Stock Titan
Rosalind Advisors, Inc. Expands Myomo Inc (MYO) Stake -- Shares Trade 48% Below GF Value - GuruFocus
Myomo (MYO) Shows Fast-paced Momentum But Is Still a Bargain Stock - qz.com
Myomo Inc. (MYO) Q2 2026 Earnings: EPS Misses Estimates as Loss Deepens, Shares Edge Up - Vinanet
Myomo (MYO): Rosalind Master Fund reports 9.18% stake and warrant blocker - Stock Titan
Q1 2026 Myomo Inc Earnings Call Transcript - GuruFocus
Q3 Earnings Estimate for Myomo Issued By HC Wainwright - MarketBeat
MYO Q2 2026 Earnings: EPS Miss of 18.8% Weighs on Shares as Loss DeepensShare Repurchase Impact - Vinanet
Myomo Q2 Earnings Call Highlights - sharewise.com
Myomo revenue up 21% to USD 11.7M in Q2 2026 - Medical Buyer
Myomo earnings beat by $0.01, revenue topped estimates - Investing.com Nigeria
Craig-Hallum Maintains Myomo(MYO.US) With Buy Rating, Raises Target Price to $1.7 - Moomoo
Myomo Inc. (MYO) Surges 19% as Medical Robotics Stock Tests Key ResistanceDaily Profile - Vinanet
Myomo Inc (MYO) (Q2 2026) Earnings Call Highlights: Record Orders and Margin Expansion Drive Strong Quarter - GuruFocus
Myomo Inc (MYO) (Q2 2026) Earnings Call Highlights: Record Orders and Margin Expansion Drive ... - Yahoo Finance
Myomo Reports Second Quarter 2026 Financial and Operating Results - BioSpace
Earnings call transcript: Myomo tops Q2 2026 estimates and lifts revenue view - Investing.com
Is Myomo Inc (MYO) a Hidden Gem? Q2 Earnings Show Revenue of $11 - GuruFocus
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Aug 05 (Reuters)Myomo Inc Q2 Operating Exp - Moomoo
MYOMO INC Q2 NET INCOME USD -1.2 MILLION - Moomoo
Q2 2026 Myomo Inc Earnings Call Transcript - GuruFocus
Press Release: Myomo Reports Second Quarter 2026 Financial and Operating Results - moomoo.com
Myomo(MYO) Stock Options Chain | Quotes & News - Moomoo
Myomo Q2 2026 earnings: Gross margin expansion narrows the operating loss - TradingKey
MYO Q1 2026 Earnings: Loss Narrows to $0.05 Per Share, Beating Estimates by 56.6%Tangible Book Value - Vinanet
Myomo Adds Seventh Director to its Board - Medical Product Outsourcing
Earnings Preview: Myomo to Report Financial Results Post-market on August 05 - Moomoo
Myomo Inc. (MYO) Pushes Toward Resistance After 7.5% Gain — Key Levels to WatchBullish Percent Index - dars.gov.et
Myomo Inc. Q1 2026 Earnings: Wider-Than-Expected Loss but Significant EPS Surprise Marks ProgressShare Dilution Risk - dars.gov.et
Myomo Inc (MYO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Myomo Inc (MYO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Myomo Inc (MYO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Myomo Inc (MYO) Cash Flow - TradingKey
MYO|Myomo Inc|Price:0.990|Chg%:+0.020 - TradingKey
Myomo Inc (MYO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Myomo Inc (MYO) Institutional Confidence - TradingKey
MYO|Myomo Inc|Price:0.970|Chg%:-0.012 - TradingKey
Myomo Inc. Revenue Breakdown – AMEX:MYO - TradingView
Myomo Inc (MYO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Myomo Boosts MyoPro Availability in U.S. - Medical Product Outsourcing
Myomo Inc. (MYO) Surges 11% as Shares Bounce from Support Near $1Regression Channel - Vinanet
MYO Q1 2026 Earnings: Narrowing Losses Beat Estimates, Stock RisesSlow Growth Warning - Vinanet
Myomo Inc. (MYO) Drops 9.5% as Shares Test Critical Support Near $0.90Intraday Trade Ideas - dars.gov.et
MYO Q1 2026 Earnings: Narrower-than-Expected Loss Highlights Operational ProgressGrowth Acceleration Report - Vinanet
Form 144 MYOMO For: 13 July By Investing.com - Investing.com Nigeria
Form 4 Myomo Inc For: 13 July By Investing.com - Investing.com Nigeria
Form 4 Myomo Inc For: 13 July - Investing.com India
Myomo (MYO) CFO receives RSU grant and disposes shares for taxes - Stock Titan
Myomo (Ticker: MYO) CEO trades 3 months salary for 10,454 RSUs - Stock Titan
Myomo (MYO) insider to sell 5,166 shares tied to RSU vesting - Stock Titan
Finanzdaten der Myomo Inc-Aktie (MYO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):